Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MIF | P14174 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | BCHE | P06276 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | APEX1 | P27695 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.34 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.34 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14625722 | 0.78 | MIF (0.60) | MIFALDH1A1BCHEPOLBMAOA | |
| Benzoquinone SCHEMBL26923622 | 0.76 | TDP1 (0.57) | MIFALDH1A1BCHEPOLBMAOA | |
| Benzoquinone SCHEMBL28301048 | 0.73 | ALDH1A1 (0.53) | MIFALDH1A1BCHEPOLBMAOA | |
| Benzoquinone SCHEMBL28873562 | 0.71 | TDP1 (0.50) | MIFALDH1A1BCHEPOLBMAOA | |
| Benzoquinone SCHEMBL5963896 | 0.67 | TDP1 (0.61) | MIFALDH1A1BCHEPOLBMAOA | |
| Benzoquinone SCHEMBL29032303 | 0.66 | TDP1 (0.73) | MIFALDH1A1BCHEPOLBMAOA | |
| SCHEMBL15805139 | 0.66 | — | — | |
| Benzoquinone SCHEMBL27473702 | 0.64 | TDP1 (0.57) | MIFALDH1A1BCHEPOLBMAOA | |
| Water SCHEMBL19744836 | 0.64 | MIF (0.48) | MIFALDH1A1BCHEPOLBMAOA | |
| Benzoquinone SCHEMBL28211057 | 0.62 | TDP1 (0.80) | MIFALDH1A1BCHEPOLBMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230142627-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | POP TEST ONCOLOGY LLC (US) | 2023-05-11 | — | — | US | disclosed |
| US-11576921-B2 | Pharmaceutical compositions and methods | POP TEST ONCOLOGY LLC (US) | 2023-02-14 | — | — | US | disclosed |
| US-20170128465-A1 | Pharmaceutical Compositions and Methods | POP TEST ONCOLOGY LLC (US) | 2017-05-11 | — | — | US | disclosed |
| US-9598459-B2 | Pharmaceutical compositions and methods | POP TEST ONCOLOGY LLC (US) | 2017-03-21 | — | — | US | disclosed |
| US-20170051007-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | POP TEST ONCOLOGY LLC | 2017-02-23 | — | — | US | disclosed |
| WO-2017023694-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | POP TEST ONCOLOGY LLC (US) | 2017-02-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170051007-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | NR3C2, NR3C1, MC2R | MIF 824/4885ALDH1A1 1768/4885BCHE 2907/4885 |
| US-20170128465-A1 | Pharmaceutical Compositions and Methods | NR3C2, NR3C1, MC2R | MIF 824/4885ALDH1A1 1768/4885BCHE 2907/4885 |
| US-11576921-B2 | Pharmaceutical compositions and methods | NR3C2, NR3C1, MC2R | MIF 824/4885ALDH1A1 1768/4885BCHE 2907/4885 |
| US-20230142627-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | NR3C2, NR3C1, MC2R | MIF 824/4885ALDH1A1 1768/4885BCHE 2907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.